Stock Updates

Today’s Top Gainers in the Market Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) from Healthcare

Today’s top gainers include the company Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) which is in the industry Biotechnology, gaining -1.53% today. In the last week its performance is 0.32%, and 22.07% for the past quarter. Currently, Regeneron Pharmaceuticals, Inc., REGN has a target price of 467.86, so today’s gain of -1.53% is a significant step towards its target price. The GAP today is therefore -0.10%.

Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), has a market cap of 42549.79, and is based in USA. Insider ownership is at 0.50%, and institutional ownership is 70.90%.

At the current price of 404.12, it has a dividend yield of *TBA, and its target price is 467.86. This is with a profit margin of 16.00%, and total debt/equity of 0.09. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has a P/E of 63.08, as well as a forward P/E of 27.83.

With a current EPS of 6.41, and a forecasted EPS growth for next year at 32.01%,Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has had a EPS growth for the past five years at 44.90%. For the next five years EPS growth is projected to be 18.62%.

Performance for the year is -17.64%. Since its IPO date on 4/2/1991, the total performance to date is -25.56%.

Volume today for Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN), is 658600, while its average volume is 774.72. Whilst the total gain today was -1.53%, it did have a day high of -8.98%.

Volatility for this week has been at 2.13%, and 2.36% for the month. The 52-week low for Regeneron Pharmaceuticals, Inc., REGN has been 22.80%, while the 52-week-high has reached -31.80%.

Looking at its return of investments, which is 16.00%, and its return on assets is 13.00%. Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) has an operating margin of 26.70%. With a sales growth of 21.40% quarter over quarter. Bearing in mind that Regeneron Pharmaceuticals, Inc., REGN is in the sector Healthcare, its long-term debt/equity is 0.09, and has a current ratio of 3.4 and 3.1 for quick ratio.

So what is the value of Regeneron Pharmaceuticals, Inc.? Well its PEG is 3.39, and the P/S is 9.15, along with a P/B of 10.37. Meanwhile it has a p/cash of 40.71.

Disclaimer: Remember there is a risk to your investment, this is not a recommendation, nor personal advice, never invest more than you are able too loose.

About the author

Peter Clarke

Leave a Comment